After treatment of central nervous system tumors, neuroendocrine dysfunction is common, especially that of the GH - IGF-I system. We expect that therapy with GHRH or GH (as appropriate) will accelerate linear growth and lead to the accrual of lean body mass.
Showing the most recent 10 out of 674 publications